Find the latest pharmaceutical market place for formulations enquiry about Elotuzumab on PharmaCompass.com.

Tender// Various Finished Dosage Formulations needed in Poland [ENA16344]

Szpital Wojewodzki w Opole sp. z oo is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 6-Mar-2023.
1. Elotuzumab (300 mg) Powder for Concentrate for Solution for Infusions. The required quantity is 20,000 units.
2. Luspatercept (25 mg) Powder for Solution for Injections. The required quantity is 1,500 units.

Reply

10 Feb 2023